论文信息 - Rituximab-CHOP Consortium Program demonstrates high-risk gene expression signatures : a report from The activated B-cell subtype of diffuse large B-cell lymphoma and MYC / BCL 2 protein coexpression contributes to the inferior survival of - 字舞流文

Rituximab-CHOP Consortium Program demonstrates high-risk gene expression signatures : a report from The activated B-cell subtype of diffuse large B-cell lymphoma and MYC / BCL 2 protein coexpression contributes to the inferior survival of

W. Choi | R. Gascoyne | G. Slack | M. Piris | Wei-min Liu | G. Bhagat | Y. Zu | Fan Zhou | K. Young | L. Medeiros | K. Richards | M. Møller | J. Huh | S. Montes-Moreno | C. Visco | E. Hsi | M. Ponzoni | A. Ferreri | Yong Li | R. Miranda | K. Dybkaer | A. Chiu | R. Go | W. Ai | Weina Chen | A. Tzankov | A. Orazi | D. Variakojis | Shimin Hu | Xiaoying Zhao | Qin Huang | Lin Wu | M. Tu | A. Balasubramanyam | J. Krieken | Xu Zijun | T. Green | Z. Xu-Monette | S. Montes-Moreno | M. Møller